Thomas Mondritzki is a Laboratory Head of In-Vivo Pharmacology at Bayer Pharmaceuticals, specializing in cardiovascular diseases with over 20 years of experience. Since 2016, they have led innovative projects focused on integrating e-health strategies into preclinical research, developing CV disease models, and fostering international collaborations. Thomas has also contributed to the fields of neurotoxicology and heart and vascular disease through significant research roles at Bayer from 1993 to 1996. They hold a Dr. rer. medic. from Universität Witten/Herdecke and a Master of Science in Clinical Research from Donau-Universität Krems, alongside vocational training as a Certified Research Technician.
This person is not in the org chart
This person is not in any teams
This person is not in any offices